Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland.
Addex Therapeutics stock last closed at $0.70, up 0.14% from the previous day, and has decreased 80.5% in one year. It has underperformed other stocks in the Biotechnology industry by 0.68 percentage points. Addex Therapeutics stock is currently +27.27% from its 52-week low of $0.55, and -82.5% from its 52-week high of $4.00.
There are currently 63.43M ADXN shares outstanding. The market value of ADXN is $7.42M. In the past 24 hours, 59,128 ADXN shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy ADXN shares.
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your share purchase by opening an account with eToro today.Open eToro Account
Now that you've picked the right brokerage, it's time to fill out some personal information so you are able to buy ADXN stock today.
Now that you have finished signing up on the best beginner stock app, you need to deposit funds:
Check out this video walkthrough to see the process of transferring money into your investment account.
After you have figured out the best place to buy Addex Therapeutics stock, it's very important to analyze their stock before you buy, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was designed to help average investors do better fundamental analysis quickly.
You can view all of the due diligence checks on ADXN's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ADXN's intrinsic value.
Using relative valuations ratios:
You can do more valuation analysis on ADXN's stock here.
You can dive deeper into what analysts are saying on the Addex Therapeutics stock forecast page.
Last year, ADXN revenue was $1.89M. During the last three year, ADXN's revenue has grown by -73.7% per year. This was slower than the Biotechnology industry average of 90.44%.
Find out more about ADXN's earnings and revenue performance here.
Over the past year, executives and large shareholders at ADXN have not bought or sold any shares.
Research more about who owns ADXN stock here.
No, Addex Therapeutics doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two primary options:
Hit the Open button and your broker will execute your order.
If you want more info about investing in stocks on eToro, watch the how to video below:
Now that you own some ADXN shares, you'll want to keep up with your new shares.
Put ADXN on a watchlist to get notified of the latest news about your ADXN stock.
To reiterate, here are the 6 steps to buy stock in Addex Therapeutics:
If you are looking for a online brokerage, eToro is our recommended venue.Get Started with eToro Today
If you want to get the latest news on your new investment in Addex Therapeutics, click the button below.
How much does it cost to buy one Addex Therapeutics share?
What is the best way to buy Addex Therapeutics stock?